Delivery Order SPE2DB22D3016-SPE2DB24FBDJ4
Award Date
8/8/24
Potential Completion Date
8/9/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,911.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 0.5% Ophthalmic Solution, a medication used to treat eye pain and inflammation. This is a Firm Fixed Price Delivery Order contract with a completion date of January 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of Ketorolac 0.4% ophthalmic solution, a prescription eye medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm fixed-price basis for a total ceiling value of $2,047.08. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This...
This federal contract award, with ID SPE2DX15D1022|SPE2DX24FVEMP, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ketorolac 0.4% ophthalmic solution, a pain management medication, with a ceiling value of $3,540.13. The contract is a Firm Fixed Price Delivery Order, with a performance period ending on March 11, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.10, was awarded by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 0.5% ophthalmic solution, a medication commonly used to treat eye-related pain and inflammation. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of December 13, 2024. This award is not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,416.00 firm fixed-price delivery order is for the supply of Ketorolac 0.5% ophthalmic solution 5ml. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $3,044.27, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ketorolac 0.5% ophthalmic solution, a prescription medication used to treat eye inflammation. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical....
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $7,542.83 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4564247323 - Ketorolac 0.5% Ophthalmic Solution 5ML. The contract has an ultimate completion date of April 12, 2024. This delivery order is issued under Amerisourcebergen's single-award indefinite delivery contract with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ketorolac 0.5% ophthalmic solution in 10 ml bottles. The $3,564.79 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, on April 15, 2024, with a planned completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ketorolac 0.5% ophthalmic solution (5 ml). The delivery order, valued at $1,166.40, has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. This IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ketorolac 0.5% ophthalmic solution in 10 mL vials. The contract has a ceiling value of $2,520.00 and is a delivery order placed under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2025. The DLA IDC serves as the primary vehicle for Amerisourcebergen to deliver a...